US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 2.2000
  • -0.1000-4.35%
Close Mar 28 16:00 ET
  • 2.3100
  • +0.1100+5.00%
Post 17:03 ET
162.91MMarket Cap-1.79P/E (TTM)

Perspective Therapeutics Key Stats

Perspective Therapeutics Q4 2024 Earnings Date

Currency:USDMar 26, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.24
-0.61
-0.37
Miss Est.
+73.17%
+93.30%
-152.69%
Net Income
--
-40.17M
--
-62.79%
Strong Buy

Mar 28, 2025

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 153.960K--
--2025/Q1-- / 153.170K--
Mar 26, 20252024/Q4234.000K / 302.510K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 153.960K--
--2025/Q1-- / 153.170K--
Mar 26, 20252024/Q4234.000K / 302.510K--
Nov 12, 20242024/Q3369.000K / 237.910K--
Aug 12, 20242024/Q2526.000K / 135.630K--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 28, 2025

Strong Buy

  • Buy

    90.91%
  • Hold

    9.09%
  • Sell

    0.00%

Price Target

No Data